These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3055347)

  • 1. [Multicenter cooperative study of immunosuppressive therapy of systemic lupus erythematosus--a report of Therapy Research Division of Research Committee for Autoimmune Diseases, the Ministry of Health and Welfare].
    Ichikawa Y; Tanaka H; Hirose S; Yokohari R; Tsunematsu T
    Ryumachi; 1988 Aug; 28(4):230-9. PubMed ID: 3055347
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents.
    Vasquez S; Kavanaugh AF; Schneider NR; Wacholtz MC; Lipsky PE
    J Rheumatol; 1992 Oct; 19(10):1625-7. PubMed ID: 1464880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus.
    Lavalle-Graef A; Villegas-Acosta L; Lavalle C
    Arch Med Res; 2004; 35(5):421-7. PubMed ID: 15610913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of autoimmune nephropathy with steroids and cytostatics. A follow-up study of 80 patients and of 16 years.
    Petrányi G; Leövey A; Szegedi G; Kakuk G; Bobory J
    Acta Med Acad Sci Hung; 1971; 28(1):97-106. PubMed ID: 5133501
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive therapy in systemic lupus erythematosus.
    Russell AS; Bretscher PA
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():194-8. PubMed ID: 3302253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Remote results of combined immunosuppressive treatment of systemic lupus erythematosus (1969-1978)].
    Wysocka K; Kiczak J; Hawrlylak E
    Wiad Lek; 1979 Nov; 32(22):1591-4. PubMed ID: 538910
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunosuppressive therapy of systemic lupus erythematosus].
    Miescher PA; Lambert PH
    Ther Umsch; 1971 Sep; 28(9):579-85. PubMed ID: 5122520
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multicenter study of causes of death in systemic lupus erythematosus-a report from the Subcommittee for Development of Therapy, the Research Committee for Autoimmune Diseases Supported by the Ministry of Health and Welfare].
    Ichikawa Y; Tsunematsu T; Yokohari R; Tanimoto K; Sakane T; Yoshida H; Kano S; Sawada S; Hashimoto H; Nagasawa T
    Ryumachi; 1985 Sep; 25(4):258-64. PubMed ID: 4081905
    [No Abstract]   [Full Text] [Related]  

  • 9. Innovative management of lupus erythematosus.
    Knott HM; Martínez JD
    Dermatol Clin; 2010 Jul; 28(3):489-99. PubMed ID: 20510759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA; McCune WJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic lupus erythematosus. Etiopathogenesis and immunosuppressive therapy].
    Clément F
    Schweiz Med Wochenschr; 1973 Oct; 103(40):1369-77. PubMed ID: 4755631
    [No Abstract]   [Full Text] [Related]  

  • 12. [So-called immunosuppressive cytotoxic medication in acute disseminated lupus erythematosus and scleroderma].
    Thivolet J; Perrot H
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):412-4. PubMed ID: 5510738
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunosuppressive long-term therapy of autoimmune diseases in hematology].
    Nelius D; Stieglitz R
    Z Gesamte Inn Med; 1972 Jun; 27(11):480-3. PubMed ID: 4626749
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of systemic lupus erythematosus with immunosupressive agents. Results of our experience and review of the literature].
    Kahn MF; Rambouts C; de Sèze S
    Sem Hop; 1971 Feb; 47(7):435-45. PubMed ID: 4323077
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].
    Purice S; Ghelerter L; Matei I; Brunazian G
    Stud Cercet Med Interna; 1969; 10(2):147-53. PubMed ID: 5344004
    [No Abstract]   [Full Text] [Related]  

  • 16. High dose cyclophosphamide in the treatment of systemic lupus erythematosus.
    Mittal G; Balakrishnan C; Mangat G; Joshi VR
    J Assoc Physicians India; 1999 Jul; 47(7):747. PubMed ID: 10778607
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug alternatives in therapy of neuropsychiatric systemic lupus erythematosus (NPSLE)].
    Harten P
    Med Klin (Munich); 2003 Jun; 98(6):344; author reply 344-5. PubMed ID: 12877108
    [No Abstract]   [Full Text] [Related]  

  • 18. [The immunosuppressive agents. 3. The immunosuppressive agents in hematology].
    Meshaka G; Jacquillat C; Sultan Y
    Presse Med (1893); 1967 Jul; 75(32):1653-5. PubMed ID: 6067478
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study.
    Mok CC; Lau CS; Wong RW
    Am J Med; 2003 Jul; 115(1):59-62. PubMed ID: 12867236
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy.
    Rood MJ; Borggreve SE; Huizinga TW
    J Rheumatol; 2000 Aug; 27(8):2057-9. PubMed ID: 10955362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.